Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
Company profile
Website
CEO
Alfred F. Altomari
Employees
Location
Industry (SIC)
Former names
Nociceptech Pharmaceuticals Inc
SEC CIK
Corporate docs
Latest filings (excl ownership)
RW
Registration withdrawal request
15 Dec 05
425
Business combination disclosure
6 Dec 05
425
Business combination disclosure
2 Dec 05
425
Business combination disclosure
1 Dec 05
425
Business combination disclosure
29 Nov 05
425
Business combination disclosure
17 Nov 05
425
Business combination disclosure
16 Nov 05
425
Business combination disclosure
15 Nov 05
425
Business combination disclosure
9 Nov 05
425
Business combination disclosure
8 Nov 05
Latest ownership filings
No filings